US81725T1007 - Common Stock

Taking everything into account, **SXT** scores **5** out of 10 in our fundamental rating. **SXT** was compared to 85 industry peers in the **Chemicals** industry. **SXT** has an average financial health and profitability rating. **SXT** is valied quite expensively at the moment, while it does show a decent growth rate.

Each year in the past 5 years **SXT** had a positive operating cash flow.

With a decent **Return On Invested Capital** value of **7.62%**, **SXT** is doing good in the industry, outperforming **68.24%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 4.64% | ||

ROE | 8.87% | ||

ROIC | 7.62% |

ROA(3y)6.18%

ROA(5y)5.91%

ROE(3y)11.87%

ROE(5y)11.33%

ROIC(3y)8.31%

ROIC(5y)7.82%

In the last couple of years the **Operating Margin** of **SXT** has declined.

Looking at the **Gross Margin**, with a value of **31.82%**, **SXT** is in the better half of the industry, outperforming **67.06%** of the companies in the same industry.

In the last couple of years the **Gross Margin** of **SXT** has remained more or less at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 12.56% | ||

PM (TTM) | 6.41% | ||

GM | 31.82% |

OM growth 3Y-0.78%

OM growth 5Y-3.06%

PM growth 3Y-7.95%

PM growth 5Y-10.79%

GM growth 3Y-0.22%

GM growth 5Y-1.09%

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), **SXT** is creating some value.

The number of shares outstanding for **SXT** has been increased compared to 1 year ago.

Looking at the **Debt to FCF ratio**, with a value of **8.05**, **SXT** is in line with its industry, outperforming **57.65%** of the companies in the same industry.

A Debt/Equity ratio of **0.63** indicates that **SXT** is somewhat dependend on debt financing.

The **Debt to Equity ratio** of **SXT** (**0.63**) is comparable to the rest of the industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.63 | ||

Debt/FCF | 8.05 | ||

Altman-Z | N/A |

ROIC/WACC0.95

WACC8.05%

A Current Ratio of **3.96** indicates that **SXT** has no problem at all paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 3.96 | ||

Quick Ratio | 1.43 |

The **Earnings Per Share** has been decreasing by **-9.79%** on average over the past years.

The **Revenue** has been growing slightly by **0.98%** on average over the past years.

EPS 1Y (TTM)-33.78%

EPS 3Y-5.14%

EPS 5Y-9.79%

EPS growth Q2Q-120.13%

Revenue 1Y (TTM)1.35%

Revenue growth 3Y3.02%

Revenue growth 5Y0.98%

Revenue growth Q2Q0.16%

Based on estimates for the next years, **SXT** will show a quite strong growth in **Earnings Per Share**. The EPS will grow by **13.75%** on average per year.

EPS Next Y8.4%

EPS Next 2Y10.04%

EPS Next 3Y13.75%

EPS Next 5YN/A

Revenue Next Year4.98%

Revenue Next 2Y4.32%

Revenue Next 3Y6.13%

Revenue Next 5YN/A

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The average S&P500 **Price/Forward Earnings** ratio is at **21.63**. **SXT** is around the same levels.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 30.63 | ||

Fwd PE | 21.21 |

The rest of the industry has a similar **Enterprise Value to EBITDA** ratio as **SXT**.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 34.95 | ||

EV/EBITDA | 14.26 |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

PEG (NY)3.64

PEG (5Y)N/A

EPS Next 2Y10.04%

EPS Next 3Y13.75%

Compared to an average industry **Dividend Yield** of **3.58**, **SXT** pays a bit more dividend than its industry peers.

Compared to an average S&P500 **Dividend Yield** of **2.45**, **SXT** has a dividend comparable with the average S&P500 company.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.46% |

The dividend of **SXT** has a limited annual growth rate of **4.12%**.

Dividend Growth(5Y)4.12%

Div Incr Years17

Div Non Decr Years20

The dividend of **SXT** is growing, but earnings are growing more, so the dividend growth is sustainable.

DP74.12%

EPS Next 2Y10.04%

EPS Next 3Y13.75%

**SENSIENT TECHNOLOGIES CORP**

NYSE:SXT (2/23/2024, 7:14:02 PM)

After market: 67.69 0 (0%)**67.69**

**+1.06 (+1.59%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap2.86B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.46% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 30.63 | ||

Fwd PE | 21.21 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)3.64

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 4.64% | ||

ROE | 8.87% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 12.56% | ||

PM (TTM) | 6.41% | ||

GM | 31.82% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.72

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.63 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 3.96 | ||

Quick Ratio | 1.43 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-33.78%

EPS 3Y-5.14%

EPS 5Y

EPS growth Q2Q

EPS Next Y8.4%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)1.35%

Revenue growth 3Y3.02%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y